UroNucleo SYNERGYCON 2025 is a groundbreaking Continuing Medical Education (CME) conference bringing together leading experts in urology, nuclear medicine, and oncology. Scheduled under the esteemed guidance of ICNM and SNMI, this event will be hosted by the renowned RNM Center in Rohtak. CME UroNucleo SYNERGYCON 2025 aims to create a collaborative platform for medical professionals to exchange insights on the role of nuclear medicine and theranostics in urological cancers. The event will feature keynote lectures, clinical workshops, and discussions on advanced imaging, targeted therapy, and patient-centered care. Attendees will gain hands-on experience in emerging diagnostic tools and radionuclide therapies that are transforming prostate and kidney cancer treatment. Designed for oncologists, radiologists, urologists, and nuclear medicine specialists, this CME will advance clinical knowledge and improve interdisciplinary patient care. With Rohtak as a hub for cutting-edge cancer treatment, UroNucleo SYNERGYCON 2025 sets a new standard for innovation and collaboration in oncological healthcare. Call us: +91 96712 06780
No comments:
Post a Comment